Prognosis Stage 10 Prostate Cancer
Published on Mar 09 2010, in the categories: Stages of disease, Useful Info
Prognosis stage 10 prostate cancer - The best prognosis can be made for patients with slow-growing, smaller, well differentiated tumors. The prognosis tends to depend on the stage and grade of the cancer more than the choice of treatment. The 5 year prognosis can be considered excellent in the case that cancer is moderately or well differentiated and is limited to the prostate.
The 5 year prognosis can be considered excellent for the following three treatment options: surgery, watchful waiting, and radiation therapy. This prognosis works well when cancer stays to the prostate area (stages 1 and II). On the Gleason score has to be lower than 7 and has to be moderately differentiated. Men suffering from prostate cancer have a high rate of survival even in 10 years if they have a lower Gleason score and their cancer is in the stage I or II.
The degree of aggressiveness of prostate cancer can be graded differently. The Gleason score for grading starts from 2 (the form of cancer the least aggressive) up to 10 (the form of cancer that is the most aggressive). The majority of patient has developed prostate cancer graded with 5-7 on a Gleason scale. Detecting the cancer in the early stages can increase the survival rate from prostate cancer because it can be good for the decision to apply the proper treatment.
In the late stages of disease when the prostate cancer has spread to nearby regions it is more difficult to find a treatment that can cure it. There is a high chance of survival rate. The worst outlook can be if the pelvic lymph nodes have metastasized cancer. The average survival time for metastasized cancer that has spread to distant organs is from 1 to 3 years. In the cases the cancer has recurred after an initial treatment if is held within prostate it can be still cured. In this cases often are used hormone treatments.
The stages determined using DRE (Digital Rectal Exam) are T1c (PSA detected), T2a (small node), T2b(larger nodule), T3 (when it feels very large nodule with probable extension outside of the prostate), T4 (when prostate cancer is spreading into adjacent organ such as the bladder). Another test for detecting prostate cancer is the PSA test. When the PSA has a lower value it results in a better prognosis. Information about evolution of prostate cancer can be obtained from the percent of biopsy and the tumor volume. This method can't predict always accurately the outcome because of the risk of sampling error on routine prostate biopsy.
Gleason prostate grading system that spreads from 2 to 10 has the following explanation. In the case of the score from 2 to 4 the behavior of the tumor can be slow growing and is well differentiated. From 5 to 7 the tumor is moderately differentiated and is the intermediate form. Gleason 7 is the most common one. From 8 to 10 the tumor is poorly differentiated and has a fast growing pace. There are additional indicators that can give a more accurate overall prognosis.
The 5 year prognosis can be considered excellent for the following three treatment options: surgery, watchful waiting, and radiation therapy. This prognosis works well when cancer stays to the prostate area (stages 1 and II). On the Gleason score has to be lower than 7 and has to be moderately differentiated. Men suffering from prostate cancer have a high rate of survival even in 10 years if they have a lower Gleason score and their cancer is in the stage I or II.
The degree of aggressiveness of prostate cancer can be graded differently. The Gleason score for grading starts from 2 (the form of cancer the least aggressive) up to 10 (the form of cancer that is the most aggressive). The majority of patient has developed prostate cancer graded with 5-7 on a Gleason scale. Detecting the cancer in the early stages can increase the survival rate from prostate cancer because it can be good for the decision to apply the proper treatment.
In the late stages of disease when the prostate cancer has spread to nearby regions it is more difficult to find a treatment that can cure it. There is a high chance of survival rate. The worst outlook can be if the pelvic lymph nodes have metastasized cancer. The average survival time for metastasized cancer that has spread to distant organs is from 1 to 3 years. In the cases the cancer has recurred after an initial treatment if is held within prostate it can be still cured. In this cases often are used hormone treatments.
The stages determined using DRE (Digital Rectal Exam) are T1c (PSA detected), T2a (small node), T2b(larger nodule), T3 (when it feels very large nodule with probable extension outside of the prostate), T4 (when prostate cancer is spreading into adjacent organ such as the bladder). Another test for detecting prostate cancer is the PSA test. When the PSA has a lower value it results in a better prognosis. Information about evolution of prostate cancer can be obtained from the percent of biopsy and the tumor volume. This method can't predict always accurately the outcome because of the risk of sampling error on routine prostate biopsy.
Gleason prostate grading system that spreads from 2 to 10 has the following explanation. In the case of the score from 2 to 4 the behavior of the tumor can be slow growing and is well differentiated. From 5 to 7 the tumor is moderately differentiated and is the intermediate form. Gleason 7 is the most common one. From 8 to 10 the tumor is poorly differentiated and has a fast growing pace. There are additional indicators that can give a more accurate overall prognosis.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments